MUSSINI, Cristina
 Distribuzione geografica
Continente #
NA - Nord America 37.636
EU - Europa 20.658
AS - Asia 5.731
AF - Africa 159
SA - Sud America 124
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 31
Totale 64.391
Nazione #
US - Stati Uniti d'America 37.379
GB - Regno Unito 7.617
IT - Italia 5.714
SE - Svezia 2.157
CN - Cina 1.747
DE - Germania 1.496
HK - Hong Kong 1.367
SG - Singapore 1.155
FI - Finlandia 664
UA - Ucraina 649
FR - Francia 595
TR - Turchia 496
BG - Bulgaria 486
ID - Indonesia 272
CA - Canada 222
IN - India 195
RU - Federazione Russa 161
IE - Irlanda 145
SI - Slovenia 134
NL - Olanda 132
IR - Iran 114
ES - Italia 110
LT - Lituania 106
BE - Belgio 101
VN - Vietnam 100
CH - Svizzera 80
MY - Malesia 76
RO - Romania 74
ZA - Sudafrica 72
CZ - Repubblica Ceca 66
JP - Giappone 53
AU - Australia 44
BR - Brasile 44
PL - Polonia 34
KR - Corea 31
CL - Cile 28
EU - Europa 24
GR - Grecia 24
UG - Uganda 23
AR - Argentina 22
NO - Norvegia 21
BZ - Belize 20
CO - Colombia 20
PK - Pakistan 20
RS - Serbia 19
AE - Emirati Arabi Uniti 18
EG - Egitto 16
PH - Filippine 15
MK - Macedonia 13
TH - Thailandia 13
DK - Danimarca 10
IL - Israele 10
SA - Arabia Saudita 10
TZ - Tanzania 10
BD - Bangladesh 9
PT - Portogallo 9
AT - Austria 8
ET - Etiopia 8
IQ - Iraq 8
MX - Messico 8
NZ - Nuova Zelanda 8
A2 - ???statistics.table.value.countryCode.A2??? 7
TW - Taiwan 6
HR - Croazia 5
PE - Perù 5
BO - Bolivia 4
KE - Kenya 4
LK - Sri Lanka 4
LV - Lettonia 4
SK - Slovacchia (Repubblica Slovacca) 4
ZM - Zambia 4
BA - Bosnia-Erzegovina 3
BW - Botswana 3
HU - Ungheria 3
KZ - Kazakistan 3
MD - Moldavia 3
NG - Nigeria 3
PA - Panama 3
SD - Sudan 3
AL - Albania 2
BY - Bielorussia 2
DZ - Algeria 2
EE - Estonia 2
GH - Ghana 2
MC - Monaco 2
MG - Madagascar 2
NI - Nicaragua 2
PR - Porto Rico 2
ZW - Zimbabwe 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
CI - Costa d'Avorio 1
CM - Camerun 1
CY - Cipro 1
EC - Ecuador 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LU - Lussemburgo 1
Totale 64.384
Città #
Southend 6.586
Fairfield 6.140
Woodbridge 3.404
Ashburn 3.363
Chandler 3.320
Houston 2.623
Seattle 2.340
Cambridge 2.052
Wilmington 2.019
Nyköping 1.527
Hong Kong 1.343
Ann Arbor 1.338
Jacksonville 1.286
Dearborn 1.228
Modena 836
Singapore 814
San Diego 735
Beijing 587
Princeton 547
New York 500
Sofia 477
Helsinki 460
Milan 372
Rome 344
Izmir 324
London 315
Eugene 276
Jakarta 263
Bremen 260
Bologna 247
Shanghai 211
Redwood City 186
Boardman 147
Fremont 140
Dublin 128
Des Moines 117
Munich 100
Falls Church 96
Brussels 92
Parma 91
Dong Ket 89
Naples 86
Norwalk 83
Toronto 83
Florence 71
San Jose 67
Amsterdam 65
Frankfurt am Main 63
Nanjing 62
Kilburn 61
Los Angeles 60
Madrid 54
Paris 51
Turin 51
Chicago 49
Grafing 49
Hounslow 48
Brno 46
Chiswick 45
Hefei 44
Reggio Emilia 44
Palermo 43
Phoenix 43
Catania 41
Guangzhou 41
Washington 41
Buffalo 40
Kunming 40
Leawood 38
Ottawa 38
Dallas 37
Las Vegas 37
North York 37
Bari 36
Verona 36
Padova 35
Roncoferraro 35
Perugia 34
Prescot 34
Piacenza 32
Rimini 32
Wuhan 31
Zurich 31
Brescia 30
Genoa 30
San Mateo 30
Tokyo 29
Augusta 28
Berlin 28
Lappeenranta 26
Mumbai 26
Reggio Nell'emilia 26
Bucharest 24
Bergamo 23
Jinan 23
Nanchang 21
Belize City 20
Tabriz 20
Kampala 19
Rho 19
Totale 49.739
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 1.005
Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: An Italian cost impact study 709
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 670
Comparative evaluation of subtyping tools for surveillance of newly emerging HIV-1 strains 619
Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease 550
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 519
Migration and health: A retrospective study about the prevalence of HBV, HIV, HCV, tuberculosis and syphilis infections amongst newly arrived migrants screened at the Infectious Diseases Unit of Modena, Italy 479
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 371
Granulicatella adiacens and Abiotrophia defectiva Native Vertebral Osteomyelitis: Three Cases and Literature Review of Clinical Characteristics and Treatment Approach 329
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation 312
A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity 302
Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study 286
T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy. 281
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 265
Gastric Mucormycosis in a Liver and Kidney Transplant Recipient: Case Report and Concise Review of Literature 263
Successful treatment of HIV-1 infection increases the expression of a novel, short transcript for IL-18 receptor α chain 260
Handling and processing of blood specimens from patients with Covid-19 for safe studies on cell phenotype and cytokine storm 254
Clinical outcome of kidney transplantation in HIV-infected recipients: a retrospective study 251
Analysis of inflammasomes and antiviral sensing components reveals decreased expression of NLRX1 in HIV-positive patients assuming efficient antiretroviral therapy 249
Aging with HIV infection: a journey to the center of inflammAIDS, immunosenescence and neuroHIV 244
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit 244
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 237
Exploring viral reservoir: The combining approach of cell sorting and droplet digital PCR 234
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 233
The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans 232
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 230
Acinetobacter baumannii Resistance to Sulbactam/Durlobactam: A Systematic Review 230
T cell homeostasis in centenarians: from the thymus to the periphery. 226
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study 226
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report 224
Th1 and Th17 pro-inflammatory profile characterizes iNKT cells in virologically suppressed HIV+ patients with low CD4/CD8 ratio 222
A frailty index predicts post-liver transplant morbidity and mortality in HIV-positive patients 220
Aging with HIV vs. HIV Seroconversion at Older Age: A Diverse Population with Distinct Comorbidity Profiles 216
Increased plasma levels of extracellular mitochondrial DNA during HIV infection: a new role for mitochondrial damage-associated molecular patterns during inflammation. 213
Ageing and inflammation in patients with HIV infection 212
Impact of polypharmacy on antiretroviral prescription in people living with HIV. 210
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome 210
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia 207
HIV-1 Infection and the Aging of the Immune System: Facts, Similarities and Perspectives 206
Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors 206
Cytometry, immunology, and HIV infection: Three decades of strong interactions. 204
Mitochondrial DNA Haplogroups and Highly Active Antiretroviral Therapy–Related Lipodystrophy 203
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 201
The protease inhibitor atazanavir triggers autophagy and mitophagy in human preadipocytes 200
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 200
Mucorales-specific T cells in patients with hematologic malignancies 199
Correlates of frailty phenotype and frailty index and their associations with clinical outcomes 198
Gram-positive bloodstream infections in liver transplant recipients: incidence, risk factors, and impact on survival. 197
Novel genetic association of TNF-α-238 and PDCD1-7209 polymorphisms with long-term non-progressive HIV-1 infection. 196
CD4+ T-cell differentiation, regulatory T cells and gag-specific T lymphocytes are unaffected by CD4-guided treatment interruption and therapy resumption. 196
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 196
Absence of liver steatosis in HIV-HCV co-infected patients receiving regimens containing tenofovir or abacavir 195
Intact parathyroid hormone levels are associated with increased carotid intima media thickness in HIV infected patients 195
Impact of Pre-Analytical Time on the Recovery of Pathogens from Blood Cultures: Results from a Large Retrospective Survey 195
Lower Frailty Is Associated with Successful Cognitive Aging Among Older Adults with HIV 194
Upregulation of nuclear-encoded mitochondrial LON protease in HAART-treated HIV-positive patients with lipodystrophy: implications for the pathogenesis of the disease 194
Acute human herpes virus 7 (HHV-7) encephalitis in an immunocompetent adult patient: a case report and review of literature 193
Decreased mitochondrial DNA content in subcutaneous fat from HIV-infected women taking antiretroviral therapy as measured at delivery. 193
Cytotoxic granule release dominates gag-specific CD4+ T-cell response in different phases of HIV infection. 192
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 192
The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection 190
Reliable and Accurate CD4+ T Cell Count and Percent by the Portable Flow Cytometer CyFlow MiniPOC and “CD4 Easy Count Kit-Dry”, as Revealed by the Comparison with the Gold Standard Dual Platform Technology 190
Tenofovir accelerates bone mass loss of the lumbar spine in the first years of menopause in HIV infected women 189
Apoptotic features of peripheral blood granulocytes and monocytes during primary, acute HIV infection. 188
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14 188
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 185
Changes in central adipose tissue after switching to integrase inhibitors 184
HIV-DNA content in different CD4+ T-cell subsets correlates with CD4+ cell : CD8+ cell ratio or length of efficient treatment 183
Clinical and Microbiological Characteristics of Visceral Leishmaniasis Outbreak in a Northern Italian Nonendemic Area: A Retrospective Observational Study 183
NK-cell phenotype at interruption underlies widely divergent duration of CD4+-guided antiretroviral treatment interruption. 182
Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital 181
Predictive Value of Intracellular HIV-1 DNA Levels During CD4-Guided Treatment Interruption in HIV(+) Patients 181
Stable changes in CD4+ T lymphocyte miRNA expression after exposure to HIV-1. 180
Identification and characterization of an aspartyl protease from Cryptococcus neoformans 179
Late presenters in an HIV surveillance system in Italy during the period 1992-2006. 178
MMP-7 promoter polymorphisms do not influence CD4+ recovery and changes in plasma viral load during antiretroviral therapy for HIV-1 infection. 178
Optimization strategies for HIV, hepatitis and syphilis testing in Infectious Disease Clinic and Dermatology Unit of Modena: 7-year results of collaboration experience 178
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 178
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians 177
Incidence of HCV infection amongst HIV positive men who had sex with men and prevalence data from patients followed at the Infectious Diseases Clinic of Modena, Italy 177
Compression of frailty in adults living with HIV 177
Liver steatosis and non-alcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV 177
Mitochondrial functionality and mitochondrial DNA content in lymphocytes of vertically infected human immunodeficiency virus-positive children with highly active antiretroviral therapy-related lipodystrophy. 176
Aseptic Osteonecrosis: A Newly Diagnosed Complication in HIV-Infected Patients Undergoing Liver Transplantation. 175
Congenital pyelectasis in children born from mothers on tenofovir containing therapy during pregnancy: report of two cases. 174
Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome 174
Mitochondrial DNA haplogroups and incidence of lipodystrophy in HIV-infected patients on long-term antiretroviral therapy. 174
Molecular Imaging of Vascular Calcification with 18 F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus 173
Mitochondrial DNA: a proinflammatory 'enemy from within' during HIV infection? 172
Markers of cell death-activation in lymphocytes of vertically HIV-infected children naive to highly active antiretroviral therapy: the role of age. 172
HIV patients undergoing second generation antipsychotics show high cardiovascular disease burden 171
The dynamic association between Frailty, CD4 and CD4/CD8 ratio in people aging with HIV 171
Prediction of hard cardiovascular events in HIV patients 170
Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients 170
Ceftolozane/tazobactam for the treatment of serious P. aeruginosa infections: a multicenter nationwide clinical experience 170
Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia 169
Decay pattern of anti–SARS–CoV–2 antibodies in PWH 168
Persistent inflammation in HIV infection: Established concepts, new perspectives. 168
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study. 168
Quantitation of CD95 and CD95L mRNA expression in chronic and acute HIV-1 infection by competitive RT-PCR 168
Totale 23.675
Categoria #
all - tutte 334.493
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 334.493


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209.590 0 0 503 604 1.104 1.706 1.728 1.232 1.119 476 697 421
2020/202114.907 1.018 615 988 1.320 2.099 1.795 1.340 1.557 865 1.343 1.171 796
2021/202210.634 777 1.030 792 554 405 713 642 588 1.211 850 1.800 1.272
2022/202310.959 1.236 1.234 906 965 1.235 1.341 331 1.062 1.203 222 573 651
2023/20248.748 363 588 619 844 1.450 790 703 1.129 330 282 531 1.119
2024/20251.470 804 410 256 0 0 0 0 0 0 0 0 0
Totale 65.375